Article | 01.07.2026
Blog and news
topic :
category :
status :
Webinar | 15.06.2026
FibroScan® Guided VCTE® : Best Practice Review and Clinical Insights
Webinar | 15.06.2026
Multidisciplinary management of MASLD–MASH: bridging diabetology and hepatology
Webinar | 15.06.2026
How to Build & Operationalize a Successful Liver Program with FibroScan®
Press Release | 02.06.2026
Echosens Appoints Romain Baujard as Group Chief Executive Officer
White Paper | 17.04.2026
New White Paper – Vibration-Controlled Transient Elastography Explained
Webinar | 14.04.2026
Connecting the Dots: From Metabolic Risk to Liver Disease — A Primary Care Approach
Article | 06.11.2025
Statement on the acceptance by the FDA of Echosens’ Letter of Intent for Drug Development Tool (DDT)
Article | 16.09.2025
A New Era for Liver Care: Prof. Dr. Jörn Schattenberg on the EC Approval of Rezdiffra™ for MASH
Webinar | 26.08.2025
Beyond the Numbers: FibroScan® Insights for MASLD Management
Press Release | 18.08.2025
Echosens and Novo Nordisk Advance Partnership to Increase Awareness and Early Diagnosis of MASH
Press Release | 15.07.2025
Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics
Press Release | 10.06.2025
Echosens and Boehringer Ingelheim Expand Long-Standing Collaboration to Accelerate Progress in MASH Diagnosis and Care
Article | 10.06.2025
A call for doubling the diagnostic rate of at-risk MASH
Article | 13.03.2025